David Schwartz

David Schwartz is a long-standing and highly respected IP leader who brings nearly 30 years of experience in patent law. Named Ottawa’s “Lawyer of the Year” in Biotechnology Law multiple times and recognized annually as one of “The Best Lawyers in Canada” under biotechnology law since 2006, David has become the trusted go-to counsel to a broad range of biotechnology clients for complex patent prosecution. David also counsels and represents pharmaceutical and chemistry clients in patent cases. Drawing from his extensive experience, he has acted on behalf of start-ups, early-stage ventures, universities, government organizations, and multinational corporations. He advises on regulatory matters relating to the Patented Medicines (Notice of Compliance) Regulations, data protection under the Food and Drug Regulations, and matters concerning the Patented Medicine Prices Review Board. He appears regularly in oral proceedings before the Patent Appeal Board and has handled first-to-invent conflicts under the pre-1989 Patent Act. He has testified on patent law reform before both the House of Commons Standing Committee on Industry, Science and Technology and the Senate National Finance Committee. He has lectured on patent law at Queen’s University and the University of Ottawa.